Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Neurol ; 57(5): 634-41, 2005 May.
Article in English | MEDLINE | ID: mdl-15852377

ABSTRACT

Progressive supranuclear palsy (PSP) is a disorder of unknown pathogenesis. Familial clusters of PSP have been reported related to mutations of protein tau. We report the linkage of a large Spanish family with typical autosomal dominant PSP to a new locus in chromosome 1. Four members of this family had typical PSP, confirmed by neuropathology in one case. At least five ancestors had similar disease. Other members of the family have incomplete phenotypes. The power of the linkage analysis was increased by detecting presymptomatic individuals with 18F-fluoro-dopa and 18F-deoxyglucose positron emission tomography. We screened the human genome with 340 polymorphic markers and we enriched the areas of interest with additional markers. The disease status was defined according to the clinical and positron emission tomography data. We excluded linkage to the tau gene in chromosome 17. PSP was linked, in this family, to one area of 3.4 cM in chromosome 1q31.1, with a maximal multipoint < OD score of +3.53. This area contains at least three genes, whose relevance in PSP is unknown. We expect to further define the gene responsible for PSP, which could help to understand the pathogenesis of this disease and to design effective treatment.


Subject(s)
Chromosomes, Human, Pair 1/genetics , Dihydroxyphenylalanine/analogs & derivatives , Genetic Linkage/genetics , Supranuclear Palsy, Progressive/genetics , Aged , Brain Chemistry/physiology , Caudate Nucleus/diagnostic imaging , DNA/genetics , Female , Glucose/metabolism , Humans , Lod Score , Male , Middle Aged , Pedigree , Phenotype , Positron-Emission Tomography , Putamen/diagnostic imaging , Radiopharmaceuticals , Supranuclear Palsy, Progressive/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...